The Discounted Cash Flow (DCF) valuation of Amedisys Inc (AMED) is 68.44 USD. With the latest stock price at 97.16 USD, the upside of Amedisys Inc based on DCF is -29.6%.
Based on the latest price of 97.16 USD and our DCF valuation, Amedisys Inc (AMED) is a sell. selling Amedisys stocks now will result in a potential gain of 29.6%.
| Range | Selected | |
| WACC / Discount Rate | 7.2% - 10.2% | 8.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 50.26 - 108.05 | 68.44 |
| Upside | -48.3% - 11.2% | -29.6% |